CDK4 Expression in Lung Cancer
Author Information
Author(s): Wu Aibing, Wu Bin, Guo Jinsong, Luo Weiren, Wu Dong, Yang Huiling, Zhen Yan, Yu Xiaoli, Wang Hao, Zhou Ying, Liu Zhen, Fang Weiyi, Yang Zhixiong
Primary Institution: Cancer Research Institute of Southern Medical University
Hypothesis
The study aims to analyze the expression of CDK4 in lung cancer and its correlation with clinicopathologic features.
Conclusion
Overexpressed CDK4 is a potential unfavorable prognostic factor and mediates cell cycle progression by regulating the expression of p21 in lung cancer.
Supporting Evidence
- CDK4 protein was significantly increased in lung cancer tissues compared to normal tissues.
- High levels of CDK4 protein were positively correlated with pathology classification, lymph node metastasis, and clinical stage.
- Patients with higher CDK4 expression had a markedly shorter overall survival time.
Takeaway
This study found that high levels of a protein called CDK4 in lung cancer can make the disease worse and is linked to shorter survival times for patients.
Methodology
Immunohistochemistry analysis was used to assess CDK4 protein expression in lung cancer patients and normal lung tissues.
Limitations
The study had a limited sample size and was conducted at a single institution.
Participant Demographics
59 males and 30 females, ages ranging from 36 to 78 years.
Statistical Information
P-Value
P < 0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website